A Brain Penetrant Mutant IDH1 Inhibitor Provides in Vivo Survival Benefit

Scientific Reports- United Kingdom

doi 10.1038/s41598-017-14065-w

Full Text

Abstract

Available in

Categories

Multidisciplinary

Date

October 23, 2017

Authors

Raquel S. Sevilla

Peter Spacciapoli

Samanthi Perera

Christian Fischer

Publisher

Springer Science and Business Media LLC

Related search

A Brain-Penetrant MET Inhibitor Achieves Responses in Glioblastoma

Cancer Discovery

English

The Brain-Penetrant Clinical ATM Inhibitor AZD1390 Radiosensitizes and Improves Survival of Preclinical Brain Tumor Models

Science advances

Multidisciplinary

English

Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia

Annals of Hematology

English

Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity

Structural Biology

Molecular Biology

English

Structure Based Discovery of Clomifene as a Potent Inhibitor of Cancer-Associated Mutant IDH1

English

Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate

English

Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR

English

Mutant IDH1 and Seizures in Patients With Glioma

English